Bayesian Capital Management’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-6,394
Closed -$1.17M 826
2024
Q3
$1.17M Buy
+6,394
New +$947K 0.14% 215
2022
Q4
Sell
-1,965
Closed -$296K 886
2022
Q3
$296K Buy
+1,965
New +$327K 0.06% 415
2020
Q2
Sell
-2,091
Closed -$422K 630
2020
Q1
$422K Sell
2,091
-1,726
-45% -$332K 0.09% 343
2019
Q4
$714K Buy
+3,817
New +$657K 0.12% 227
2018
Q4
Sell
-5,613
Closed -$1.59M 685
2018
Q3
$1.59M Buy
5,613
+2,400
+75% +$703K 0.26% 98
2018
Q2
$943K Buy
3,213
+1,797
+127% +$491K 0.21% 120
2018
Q1
$357K Sell
1,416
-1,601
-53% -$376K 0.09% 356
2017
Q4
$652K Buy
+3,017
New +$611K 0.13% 263
2017
Q3
Sell
-1,624
Closed -$280K 554
2017
Q2
$280K Buy
+1,624
New +$261K 0.1% 304
2016
Q4
Sell
-2,112
Closed -$267K 643
2016
Q3
$267K Buy
+2,112
New +$255K 0.18% 222
2016
Q2
Sell
-2,150
Closed -$224K 468
2016
Q1
$224K Buy
2,150
+7
+0.3% +$669 0.21% 244
2015
Q4
$242K Buy
+2,143
New +$237K 0.35% 138

Other funds holding ICUI

Bayesian Capital Management's ICUI Position: Q4 2024 in Review

Bayesian Capital Management sold out of ICU Medical (ICUI) in Q4 2024, closing a stake of 6,394 shares — an estimated $1.17M sold.

Bayesian Capital Management first reported a position in ICUI in Q4 2015 and held it in 12 quarters. The position peaked at $1.59M in Q3 2018. 286 funds tracked by Wall St. Rank hold ICUI as of Q4 2024.

  • Bayesian Capital Management reported no remaining ICU Medical position as of Q4 2024 after selling out during the quarter.
  • Bayesian Capital Management sold 6,394 ICU Medical shares in Q4 2024, an estimated $1.17M.
  • Bayesian Capital Management first reported a position in ICU Medical in Q4 2015 and held it in 12 quarters.
  • Bayesian Capital Management's ICU Medical position peaked at $1.59M in Q3 2018.
  • 286 funds tracked by Wall St. Rank held ICU Medical as of Q4 2024.

Based on Bayesian Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.